Voriconazole inhibits cross-kingdom interactions between Candida albicans and Actinomyces viscosus through the ergosterol pathway
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 53 (6) , 805-813
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81600858, 81570974)
- Science and Technology Department of Sichuan Province (2015JY0260)
This publication has 41 references indexed in Scilit:
- In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic PeriodontitisMycopathologia, 2017
- Galleria mellonellainfection models for the study of bacterial diseases and for antimicrobial drug testingVirulence, 2016
- Importance of Candida–bacterial polymicrobial biofilms in diseaseTrends in Microbiology, 2011
- Medically important bacterial–fungal interactionsNature Reviews Microbiology, 2010
- Cross-kingdom interactions:Candida albicansand bacteriaFEMS Microbiology Letters, 2009
- Dental Caries in Older AdultsDental Clinics of North America, 2005
- Adhesion of Candida albicans and Candida dubliniensis to acrylic and hydroxyapatiteColloids and Surfaces B: Biointerfaces, 2004
- Bacterial and yeast flora of root surface caries in elderly, ethnic ChineseOral Diseases, 2002
- Glycogen Synthetic and Degradative Activities by Actinomyces viscosus and Actinomyces naeslundii of Root Surface Caries and Noncaries SitesCaries Research, 1988
- Increased Smooth-Surface Caries Incidence in Gnotobiotic Rats Immunized with Actinomyces viscosusCaries Research, 1980